These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1172902)

  • 1. Ovarian function during treatment with lynoestrenol 0.5 mg daily.
    Wiese J
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):325-31. PubMed ID: 1172902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 3. [The low dosis gestagen therapy (author's transl)].
    Mall-Haefeli M; Ludwig KS; Spornitz UM; Uettwiller A
    Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):645-60. PubMed ID: 976705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of postovulatory estradiol benzoate administration on women's ovarian function.
    Oriol-Bosch A; Cortés J
    Fertil Steril; 1975 May; 26(5):405-12. PubMed ID: 1126465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation inhibition with human chorionic gonadotrophin.
    Friedrich F; Kemeter P; Salzer H; Breitenecker G
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):332-42. PubMed ID: 1172903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose progestogen treatment "luteal supplementation" on the excretion of progesterone metabolites.
    Mirhom YW; Morvay J; Szontagh FE
    Acta Eur Fertil; 1972 Jun; 3(2):141-6. PubMed ID: 4679663
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose lynestrenol as a contraceptive influence on ovarian function.
    Järvinen PA; Ylikorkala O; Ylöstalo P
    Ann Clin Res; 1974 Apr; 6(2):109-14. PubMed ID: 4837883
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey.
    Bosu WT; Edqvist LE; Lindberg P; Martinsson K; Johansson ED
    Contraception; 1976 Jun; 13(6):677-84. PubMed ID: 819211
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
    Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
    Cameron IT; Baird DT
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375).
    Johansson ED
    Acta Obstet Gynecol Scand; 1975; 54(3):217-21. PubMed ID: 1163213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous daily administration of 0.3 mg of norehtindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens.
    Larsson-Cohn U; Johansson ED; Gemzell C
    Acta Endocrinol (Copenh); 1970 May; 64(1):38-46. PubMed ID: 4195422
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
    Jones GS; Wentz AG
    Am J Obstet Gynecol; 1972 Oct; 114(3):393-404. PubMed ID: 4637460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of post-ovulatory administered oestrogens on corpus luteum function.
    Lehmann F; Just-Nastansky I; Behrendt B; Czygan PJ; Bettendorf G
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):329-36. PubMed ID: 1173491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen-excretion of amenorrheic patients during ovulation induction.
    Sas M; Resch B; Kincses L
    Acta Eur Fertil; 1972 Dec; 3(4):347-54. PubMed ID: 4679698
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-tubal sterilization problems correlated with ovarian steroidogenesis.
    Cattanach JF; Milne BJ
    Contraception; 1988 Nov; 38(5):541-50. PubMed ID: 3197418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.